Global Optical Imaging Techniques Market to Reach US$3.6 Billion by the Year 2027

Abstract: Global Optical Imaging Techniques Market to Reach US$3. 6 Billion by the Year 2027. Amid the COVID-19 crisis, the global market for Optical Imaging Techniques estimated at US$1.

New York, July 29, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Optical Imaging Techniques Industry" - https://www.reportlinker.com/p05896247/?utm_source=GNW
7 Billion in the year 2020, is projected to reach a revised size of US$3.6 Billion by 2027, growing at a CAGR of 11.4% over the analysis period 2020-2027.Optical Coherence Tomography, one of the segments analyzed in the report, is projected to grow at a 12.9% CAGR to reach US$1.7 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Hyperspectral Imaging segment is readjusted to a revised 10.3% CAGR for the next 7-year period. This segment currently accounts for a 26.5% share of the global Optical Imaging Techniques market.

The U.S. Accounts for Over 29.5% of Global Market Size in 2020, While China is Forecast to Grow at a 10.9% CAGR for the Period of 2020-2027

The Optical Imaging Techniques market in the U.S. is estimated at US$504.2 Million in the year 2020. The country currently accounts for a 29.52% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$634.4 Million in the year 2027 trailing a CAGR of 10.9% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.2% and 9.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.2% CAGR while Rest of European market (as defined in the study) will reach US$634.4 Million by the year 2027.

Near-infrared Spectroscopy Segment Corners a 19.7% Share in 2020

In the global Near-infrared Spectroscopy segment, USA, Canada, Japan, China and Europe will drive the 9.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$269.8 Million in the year 2020 will reach a projected size of US$506.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$426.4 Million by the year 2027.

Select Competitors (Total 42 Featured)

• Abbott Laboratories

• Agfa-Gevaert Group

• ASE Optics Europe

• Canon U.S.A., Inc.

• Carl-Zeiss Meditec AG

• ChemImage Corporation

• Cytoviva Inc.

• Headwall Photonics, Inc.

• Heidelberg Engineering GmbH

• Koninklijke Philips N.V.

• Leica Microsystems GmbH

• Optical Imaging Ltd.

• PerkinElmer, Inc.

• Topcon Corporation

Read the full report: https://www.reportlinker.com/p05896247/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
An Introduction to Optical Imaging
Optical Imaging: Current Market Scenario and Outlook
Developed Regions: Dominant Consumers of Optical Imaging
Technologies
EXHIBIT 1: World Optical Imaging Market by Region: Percentage
Breakdown of Revenues for Developed and Developing Regions:
( 2019 & 2025)
Developing Regions to Spearhead Future Growth
EXHIBIT 2: World Optical Imaging Market - Geographic Regions
Ranked by CAGR (Value) for 2018-2025: China, Asia-Pacific,
Latin America, Middle East, Africa, Canada, USA, Europe, and
Japan
Key Factors Driving Demand for Medical Imaging Services in
Developing Regions
Growing Healthcare Awareness
Increased Access to Healthcare and Surge in Number of Hospitals &
Clinics
Proliferation of Medical Tourism
Optical Coherence Tomography: Major Optical Imaging Technique
Robust Opportunities for Hyperspectral Imaging
Near-infrared Spectroscopy Gains Traction
Photoacoustic Tomography Set to Make Gains

2. FOCUS ON SELECT PLAYERS
Abbott Laboratories (USA)
Agfa-Gevaert Group (Belgium)
ASE Optics Europe (Spain)
Canon U.S.A., Inc. (USA)
Carl-Zeiss Meditec AG (Germany)
ChemImage Corporation (USA)
Cytoviva Inc. (USA)
Headwall Photonics, Inc. (USA)
Heidelberg Engineering GmbH (Germany)
Koninklijke Philips N.V. (Netherlands)
Leica Microsystems GmbH (Germany)
Optical Imaging Ltd. (Israel)
PerkinElmer, Inc. (USA)
Topcon Corporation (Japan)

3. MARKET TRENDS & DRIVERS
Hospitals & Clinics: Dominant Consumers of Optical Imaging
Solutions
Optical Imaging Remains Highly Relevant in Research Laboratories
Rising Prominence of Optical Imaging Technologies for
Pharmaceutical & Biotech Firms
Growing Investments in Healthcare & Lifescience Sectors Create
Conducive Environment for Growth of Optical Imaging Market
EXHIBIT 3: World Healthcare Spending & Growth (in US$ Trillion)
and % Real GDP Growth for the Years 2012 through 2018
High Growth Opportunities in Oncology Care
EXHIBIT 4: Worldwide Incidence of Cancer (2012, 2018 & 2040):
Number of New Cases Diagnosed
Growing Adoption in Cardiology Applications Bodes Well
Demographic Factors Favor Growth
Market Stands to Gain from Expanding Geriatric Population
EXHIBIT 5: Global Aging Population (in Thousands) by Age Group:
1975-2050
EXHIBIT 6: Elderly Population (60+ Years) as a Percentage of
Total Population (2015 & 2050)
EXHIBIT 7: Life Expectancy at Birth in Years of People in
Select Countries (2017)

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Optical Imaging
Techniques by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 2: World Historic Review for Optical Imaging Techniques
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 3: World 15-Year Perspective for Optical Imaging
Techniques by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Optical Coherence
Tomography by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 5: World Historic Review for Optical Coherence Tomography
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Optical Coherence
Tomography by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Hyperspectral
Imaging by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 8: World Historic Review for Hyperspectral Imaging by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Hyperspectral Imaging by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Near-infrared
Spectroscopy by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 11: World Historic Review for Near-infrared Spectroscopy
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Near-infrared
Spectroscopy by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Photoacoustic
Tomography by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 14: World Historic Review for Photoacoustic Tomography by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 15: World 15-Year Perspective for Photoacoustic
Tomography by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Oncology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 17: World Historic Review for Oncology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Oncology by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 19: World Current & Future Analysis for Ophthalmology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 20: World Historic Review for Ophthalmology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Ophthalmology by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Neurology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 23: World Historic Review for Neurology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Neurology by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 25: World Current & Future Analysis for Cardiology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 26: World Historic Review for Cardiology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Cardiology by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Other Therapeutic
Types by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 29: World Historic Review for Other Therapeutic Types by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 30: World 15-Year Perspective for Other Therapeutic Types
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 31: World Current & Future Analysis for Hospitals &
Clinics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 32: World Historic Review for Hospitals & Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 33: World 15-Year Perspective for Hospitals & Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 34: World Current & Future Analysis for Research
Laboratories by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 35: World Historic Review for Research Laboratories by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 36: World 15-Year Perspective for Research Laboratories
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 37: World Current & Future Analysis for Pharma & Biotech
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 38: World Historic Review for Pharma & Biotech by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 39: World 15-Year Perspective for Pharma & Biotech by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 40: USA Current & Future Analysis for Optical Imaging
Techniques by Technique - Optical Coherence Tomography,
Hyperspectral Imaging, Near-infrared Spectroscopy and
Photoacoustic Tomography - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 41: USA Historic Review for Optical Imaging Techniques by
Technique - Optical Coherence Tomography, Hyperspectral
Imaging, Near-infrared Spectroscopy and Photoacoustic
Tomography Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 42: USA 15-Year Perspective for Optical Imaging
Techniques by Technique - Percentage Breakdown of Value Sales
for Optical Coherence Tomography, Hyperspectral Imaging,
Near-infrared Spectroscopy and Photoacoustic Tomography for the
Years 2012, 2020 & 2027

Table 43: USA Current & Future Analysis for Optical Imaging
Techniques by Therapeutic Type - Oncology, Ophthalmology,
Neurology, Cardiology and Other Therapeutic Types - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 44: USA Historic Review for Optical Imaging Techniques by
Therapeutic Type - Oncology, Ophthalmology, Neurology,
Cardiology and Other Therapeutic Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 45: USA 15-Year Perspective for Optical Imaging
Techniques by Therapeutic Type - Percentage Breakdown of Value
Sales for Oncology, Ophthalmology, Neurology, Cardiology and
Other Therapeutic Types for the Years 2012, 2020 & 2027

Table 46: USA Current & Future Analysis for Optical Imaging
Techniques by End-Use - Hospitals & Clinics, Research
Laboratories and Pharma & Biotech - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 47: USA Historic Review for Optical Imaging Techniques by
End-Use - Hospitals & Clinics, Research Laboratories and Pharma &
Biotech Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 48: USA 15-Year Perspective for Optical Imaging
Techniques by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Research Laboratories and Pharma & Biotech
for the Years 2012, 2020 & 2027

CANADA
Table 49: Canada Current & Future Analysis for Optical Imaging
Techniques by Technique - Optical Coherence Tomography,
Hyperspectral Imaging, Near-infrared Spectroscopy and
Photoacoustic Tomography - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 50: Canada Historic Review for Optical Imaging Techniques
by Technique - Optical Coherence Tomography, Hyperspectral
Imaging, Near-infrared Spectroscopy and Photoacoustic
Tomography Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 51: Canada 15-Year Perspective for Optical Imaging
Techniques by Technique - Percentage Breakdown of Value Sales
for Optical Coherence Tomography, Hyperspectral Imaging,
Near-infrared Spectroscopy and Photoacoustic Tomography for the
Years 2012, 2020 & 2027

Table 52: Canada Current & Future Analysis for Optical Imaging
Techniques by Therapeutic Type - Oncology, Ophthalmology,
Neurology, Cardiology and Other Therapeutic Types - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 53: Canada Historic Review for Optical Imaging Techniques
by Therapeutic Type - Oncology, Ophthalmology, Neurology,
Cardiology and Other Therapeutic Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 54: Canada 15-Year Perspective for Optical Imaging
Techniques by Therapeutic Type - Percentage Breakdown of Value
Sales for Oncology, Ophthalmology, Neurology, Cardiology and
Other Therapeutic Types for the Years 2012, 2020 & 2027

Table 55: Canada Current & Future Analysis for Optical Imaging
Techniques by End-Use - Hospitals & Clinics, Research
Laboratories and Pharma & Biotech - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 56: Canada Historic Review for Optical Imaging Techniques
by End-Use - Hospitals & Clinics, Research Laboratories and
Pharma & Biotech Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 57: Canada 15-Year Perspective for Optical Imaging
Techniques by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Research Laboratories and Pharma & Biotech
for the Years 2012, 2020 & 2027

JAPAN
Table 58: Japan Current & Future Analysis for Optical Imaging
Techniques by Technique - Optical Coherence Tomography,
Hyperspectral Imaging, Near-infrared Spectroscopy and
Photoacoustic Tomography - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 59: Japan Historic Review for Optical Imaging Techniques
by Technique - Optical Coherence Tomography, Hyperspectral
Imaging, Near-infrared Spectroscopy and Photoacoustic
Tomography Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 60: Japan 15-Year Perspective for Optical Imaging
Techniques by Technique - Percentage Breakdown of Value Sales
for Optical Coherence Tomography, Hyperspectral Imaging,
Near-infrared Spectroscopy and Photoacoustic Tomography for the
Years 2012, 2020 & 2027

Table 61: Japan Current & Future Analysis for Optical Imaging
Techniques by Therapeutic Type - Oncology, Ophthalmology,
Neurology, Cardiology and Other Therapeutic Types - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 62: Japan Historic Review for Optical Imaging Techniques
by Therapeutic Type - Oncology, Ophthalmology, Neurology,
Cardiology and Other Therapeutic Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 63: Japan 15-Year Perspective for Optical Imaging
Techniques by Therapeutic Type - Percentage Breakdown of Value
Sales for Oncology, Ophthalmology, Neurology, Cardiology and
Other Therapeutic Types for the Years 2012, 2020 & 2027

Table 64: Japan Current & Future Analysis for Optical Imaging
Techniques by End-Use - Hospitals & Clinics, Research
Laboratories and Pharma & Biotech - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 65: Japan Historic Review for Optical Imaging Techniques
by End-Use - Hospitals & Clinics, Research Laboratories and
Pharma & Biotech Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 66: Japan 15-Year Perspective for Optical Imaging
Techniques by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Research Laboratories and Pharma & Biotech
for the Years 2012, 2020 & 2027

CHINA
Table 67: China Current & Future Analysis for Optical Imaging
Techniques by Technique - Optical Coherence Tomography,
Hyperspectral Imaging, Near-infrared Spectroscopy and
Photoacoustic Tomography - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 68: China Historic Review for Optical Imaging Techniques
by Technique - Optical Coherence Tomography, Hyperspectral
Imaging, Near-infrared Spectroscopy and Photoacoustic
Tomography Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 69: China 15-Year Perspective for Optical Imaging
Techniques by Technique - Percentage Breakdown of Value Sales
for Optical Coherence Tomography, Hyperspectral Imaging,
Near-infrared Spectroscopy and Photoacoustic Tomography for the
Years 2012, 2020 & 2027

Table 70: China Current & Future Analysis for Optical Imaging
Techniques by Therapeutic Type - Oncology, Ophthalmology,
Neurology, Cardiology and Other Therapeutic Types - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 71: China Historic Review for Optical Imaging Techniques
by Therapeutic Type - Oncology, Ophthalmology, Neurology,
Cardiology and Other Therapeutic Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 72: China 15-Year Perspective for Optical Imaging
Techniques by Therapeutic Type - Percentage Breakdown of Value
Sales for Oncology, Ophthalmology, Neurology, Cardiology and
Other Therapeutic Types for the Years 2012, 2020 & 2027

Table 73: China Current & Future Analysis for Optical Imaging
Techniques by End-Use - Hospitals & Clinics, Research
Laboratories and Pharma & Biotech - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 74: China Historic Review for Optical Imaging Techniques
by End-Use - Hospitals & Clinics, Research Laboratories and
Pharma & Biotech Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 75: China 15-Year Perspective for Optical Imaging
Techniques by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Research Laboratories and Pharma & Biotech
for the Years 2012, 2020 & 2027

EUROPE
Table 76: Europe Current & Future Analysis for Optical Imaging
Techniques by Geographic Region - France, Germany, Italy, UK
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 77: Europe Historic Review for Optical Imaging Techniques
by Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 78: Europe 15-Year Perspective for Optical Imaging
Techniques by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2012, 2020 & 2027

Table 79: Europe Current & Future Analysis for Optical Imaging
Techniques by Technique - Optical Coherence Tomography,
Hyperspectral Imaging, Near-infrared Spectroscopy and
Photoacoustic Tomography - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 80: Europe Historic Review for Optical Imaging Techniques
by Technique - Optical Coherence Tomography, Hyperspectral
Imaging, Near-infrared Spectroscopy and Photoacoustic
Tomography Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 81: Europe 15-Year Perspective for Optical Imaging
Techniques by Technique - Percentage Breakdown of Value Sales
for Optical Coherence Tomography, Hyperspectral Imaging,
Near-infrared Spectroscopy and Photoacoustic Tomography for the
Years 2012, 2020 & 2027

Table 82: Europe Current & Future Analysis for Optical Imaging
Techniques by Therapeutic Type - Oncology, Ophthalmology,
Neurology, Cardiology and Other Therapeutic Types - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 83: Europe Historic Review for Optical Imaging Techniques
by Therapeutic Type - Oncology, Ophthalmology, Neurology,
Cardiology and Other Therapeutic Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 84: Europe 15-Year Perspective for Optical Imaging
Techniques by Therapeutic Type - Percentage Breakdown of Value
Sales for Oncology, Ophthalmology, Neurology, Cardiology and
Other Therapeutic Types for the Years 2012, 2020 & 2027

Table 85: Europe Current & Future Analysis for Optical Imaging
Techniques by End-Use - Hospitals & Clinics, Research
Laboratories and Pharma & Biotech - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 86: Europe Historic Review for Optical Imaging Techniques
by End-Use - Hospitals & Clinics, Research Laboratories and
Pharma & Biotech Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 87: Europe 15-Year Perspective for Optical Imaging
Techniques by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Research Laboratories and Pharma & Biotech
for the Years 2012, 2020 & 2027

FRANCE
Table 88: France Current & Future Analysis for Optical Imaging
Techniques by Technique - Optical Coherence Tomography,
Hyperspectral Imaging, Near-infrared Spectroscopy and
Photoacoustic Tomography - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 89: France Historic Review for Optical Imaging Techniques
by Technique - Optical Coherence Tomography, Hyperspectral
Imaging, Near-infrared Spectroscopy and Photoacoustic
Tomography Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 90: France 15-Year Perspective for Optical Imaging
Techniques by Technique - Percentage Breakdown of Value Sales
for Optical Coherence Tomography, Hyperspectral Imaging,
Near-infrared Spectroscopy and Photoacoustic Tomography for the
Years 2012, 2020 & 2027

Table 91: France Current & Future Analysis for Optical Imaging
Techniques by Therapeutic Type - Oncology, Ophthalmology,
Neurology, Cardiology and Other Therapeutic Types - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 92: France Historic Review for Optical Imaging Techniques
by Therapeutic Type - Oncology, Ophthalmology, Neurology,
Cardiology and Other Therapeutic Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 93: France 15-Year Perspective for Optical Imaging
Techniques by Therapeutic Type - Percentage Breakdown of Value
Sales for Oncology, Ophthalmology, Neurology, Cardiology and
Other Therapeutic Types for the Years 2012, 2020 & 2027

Table 94: France Current & Future Analysis for Optical Imaging
Techniques by End-Use - Hospitals & Clinics, Research
Laboratories and Pharma & Biotech - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 95: France Historic Review for Optical Imaging Techniques
by End-Use - Hospitals & Clinics, Research Laboratories and
Pharma & Biotech Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 96: France 15-Year Perspective for Optical Imaging
Techniques by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Research Laboratories and Pharma & Biotech
for the Years 2012, 2020 & 2027

GERMANY
Table 97: Germany Current & Future Analysis for Optical Imaging
Techniques by Technique - Optical Coherence Tomography,
Hyperspectral Imaging, Near-infrared Spectroscopy and
Photoacoustic Tomography - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 98: Germany Historic Review for Optical Imaging
Techniques by Technique - Optical Coherence Tomography,
Hyperspectral Imaging, Near-infrared Spectroscopy and
Photoacoustic Tomography Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 99: Germany 15-Year Perspective for Optical Imaging
Techniques by Technique - Percentage Breakdown of Value Sales
for Optical Coherence Tomography, Hyperspectral Imaging,
Near-infrared Spectroscopy and Photoacoustic Tomography for the
Years 2012, 2020 & 2027

Table 100: Germany Current & Future Analysis for Optical
Imaging Techniques by Therapeutic Type - Oncology,
Ophthalmology, Neurology, Cardiology and Other Therapeutic
Types - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 101: Germany Historic Review for Optical Imaging
Techniques by Therapeutic Type - Oncology, Ophthalmology,
Neurology, Cardiology and Other Therapeutic Types Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 102: Germany 15-Year Perspective for Optical Imaging
Techniques by Therapeutic Type - Percentage Breakdown of Value
Sales for Oncology, Ophthalmology, Neurology, Cardiology and
Other Therapeutic Types for the Years 2012, 2020 & 2027

Table 103: Germany Current & Future Analysis for Optical
Imaging Techniques by End-Use - Hospitals & Clinics, Research
Laboratories and Pharma & Biotech - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 104: Germany Historic Review for Optical Imaging
Techniques by End-Use - Hospitals & Clinics, Research
Laboratories and Pharma & Biotech Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 105: Germany 15-Year Perspective for Optical Imaging
Techniques by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Research Laboratories and Pharma & Biotech
for the Years 2012, 2020 & 2027

ITALY
Table 106: Italy Current & Future Analysis for Optical Imaging
Techniques by Technique - Optical Coherence Tomography,
Hyperspectral Imaging, Near-infrared Spectroscopy and
Photoacoustic Tomography - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 107: Italy Historic Review for Optical Imaging Techniques
by Technique - Optical Coherence Tomography, Hyperspectral
Imaging, Near-infrared Spectroscopy and Photoacoustic
Tomography Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 108: Italy 15-Year Perspective for Optical Imaging
Techniques by Technique - Percentage Breakdown of Value Sales
for Optical Coherence Tomography, Hyperspectral Imaging,
Near-infrared Spectroscopy and Photoacoustic Tomography for the
Years 2012, 2020 & 2027

Table 109: Italy Current & Future Analysis for Optical Imaging
Techniques by Therapeutic Type - Oncology, Ophthalmology,
Neurology, Cardiology and Other Therapeutic Types - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 110: Italy Historic Review for Optical Imaging Techniques
by Therapeutic Type - Oncology, Ophthalmology, Neurology,
Cardiology and Other Therapeutic Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 111: Italy 15-Year Perspective for Optical Imaging
Techniques by Therapeutic Type - Percentage Breakdown of Value
Sales for Oncology, Ophthalmology, Neurology, Cardiology and
Other Therapeutic Types for the Years 2012, 2020 & 2027

Table 112: Italy Current & Future Analysis for Optical Imaging
Techniques by End-Use - Hospitals & Clinics, Research
Laboratories and Pharma & Biotech - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 113: Italy Historic Review for Optical Imaging Techniques
by End-Use - Hospitals & Clinics, Research Laboratories and
Pharma & Biotech Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 114: Italy 15-Year Perspective for Optical Imaging
Techniques by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Clinics, Research Laboratories and Pharma & Biotech
for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 115: UK Current & Future Analysis for Optical Imaging
Techniques by Technique - Optical Coherence Tomography,
Hyperspectral Imaging, Near-infrared Spectroscopy and

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05896247/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001